Welsh Welsh
en Englishaf Afrikaanssq Albanianar Arabichy Armenianaz Azerbaijanieu Basquebe Belarusianbg Bulgarianca Catalanzh-CN Chinese (Simplified)zh-TW Chinese (Traditional)hr Croatiancs Czechda Danishnl Dutchet Estoniantl Filipinofi Finnishfr Frenchgl Galicianka Georgiande Germanel Greekht Haitian Creoleiw Hebrewhi Hindihu Hungarianis Icelandicid Indonesianga Irishit Italianja Japaneseko Koreanlv Latvianlt Lithuanianmk Macedonianms Malaymt Malteseno Norwegianfa Persianpl Polishpt Portuguesero Romanianru Russiansr Serbiansk Slovaksl Slovenianes Spanishsw Swahilisv Swedishth Thaitr Turkishuk Ukrainianur Urduvi Vietnamesecy Welshyi Yiddish

Newyddion Diweddaraf

Lifftiau FDA Daliwch Raglen Therapi Gene Hemophilia B uniQure

 

Roctavian, Therapi Gene A Hemoffilia Posibl, Cael Cefnogaeth Ffres FDA

 

Therapi Gene Hemophilia B AMT-061 Yn annhebygol o fod wedi Achosi Tiwmor yr Afu

 

Therapi Gene SPK-8016 Yn Dangos Addewid Cynnar ar gyfer Hemoffilia Difrifol A.

 

Yn ôl i ben y dudalen
delwedd

Please enable the javascript to submit this form

Ynghylch

Gyda chefnogaeth grantiau addysgol gan Bayer, BioMarin, Freeline Therapeutics Limited, Pfizer Inc., Shire, Spark Therapeutics, ac uniQure, Inc.

SSL hanfodol